×
Back to Agenda
New Trial Design Approaches: Including New Endpoints
Session Chair(s)
John Reites
Chief Executive Officer, THREAD, United States
Can better endpoint structures be developed that capture disease status and medical product performance, yet still allow interpretability? Can we employ trial designs that are not ‘one size fits all’ and generate better data more efficiently?
Learning Objective : Discuss how the clinical trial enterprise may be enhanced with novel designs.
Speaker(s)
Happy 2nd Birthday ResearchKit: New Opportunities and Limitations Using ResearchKit in Your Mobile Health Studies
Chief Executive Officer, THREAD, United States
Digital Biomarkers From Real World Mobile Sensor Data in Clinical Trials: How Relevant are They?
Global Area Head, Digital Biomarker Informatics, F. Hoffmann-La Roche Ltd., Switzerland
Generating Novel Endpoints Through Mobile Technology: A Promising and Realistic New Approach to Trial Design
Vice President, Portfolio Management, TransCelerate Biopharma Inc., United States
Have an account?